Taking the Bite out of Food Allergy

Food allergies affect up to 6 percent of children under the age of 3 and around 1.5 percent of adults.1,2 That may seem like peanuts compared to the huge number of people who suffer from allergic rhinitis. But food allergies--especially peanut and tree nut allergies--pack a potentially serious punch. There is absolutely no safe way to treat or prevent them, and about 100 people die in the United States every year from food-induced anaphylaxis. The best those with severe allergies can do is carry

Written bySara Latta
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Food allergies affect up to 6 percent of children under the age of 3 and around 1.5 percent of adults.1,2 That may seem like peanuts compared to the huge number of people who suffer from allergic rhinitis. But food allergies--especially peanut and tree nut allergies--pack a potentially serious punch. There is absolutely no safe way to treat or prevent them, and about 100 people die in the United States every year from food-induced anaphylaxis. The best those with severe allergies can do is carry an emergency dose of epinephrine and avoid the offending food.

That's easier said than done. Peanuts, for example, contain some of the most potent food allergens and are often hidden ingredients in prepared foods. There have even been reports of peanut-allergic people suffering severe reactions by simply inhaling or touching peanut "dust" from commercial airline snacks.3

Hope may be on the way, however, for the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies